We synthesise complex scientific evidence and prepare it in a structured, accessible way for parliaments, administrations and the expert public — from local governments to European institutions.
We develop strategies to reduce preventable disease, analyse prevention opportunities across the life course and support public health structures at municipal, national and EU levels.
We assess emerging medical and technological developments — from longevity science to drug development — and situate them in societal, ethical and regulatory contexts.
We develop approaches that reduce the burden of disease, improve population health, and support effective prevention policies based on epidemiology, intervention research and international best practices.
We analyse scientific discoveries on healthspan — the years lived in good health. Our work includes ageing biology, preventive strategies and global policy frameworks.
We examine legislative and regulatory developments across Europe and within Germany. Our goal is policy that supports innovation while ensuring responsibility, safety and equitable access.
PRIMA Longevity Policy Institute
Non-profit organisation
(gGmbH under German law)
